Jia, Yong <br/><br/>
EGF816 Exerts Anticancer Effects in Non-Small Cell Lung Cancer by Irreversibly and Selectively Targeting Primary and Acquired Activating Mutations in the EGF Receptor.  [electronic resource] 

 -  Cancer research  Mar 2016 
 - 1591-602 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-15-2581  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cell Line, Tumor<br/>Drug Resistance, Neoplasm--drug effects<br/>ErbB Receptors--metabolism<br/>Female<br/>Lung Neoplasms--drug therapy<br/>Mice<br/>Mice, Nude<br/>Mutation--drug effects<br/>Phosphorylation--drug effects<br/>Rats<br/>Xenograft Model Antitumor Assays--methods